They are primarily prescribed for the management of type 2 diabetes mellitus (semaglutide [Ozempic], liraglutide [Victoza], dulaglutide [Trulicity], exenatide [Byetta, Bydureon BCise]) and, with separate formulations, for weight management in adults with obesity or overweight with weight-related comorbidities (semaglutide [Wegovy], liraglutide [Saxenda])
In one placebo-controlled trial, AD patients who received a daily multi-strain probiotic for 12 weeks had significantly better Mini-Mental State Exam scores and lower blood inflammatory markers than those on placebo [144]
Neurocognitive peptides specifically target the brain and nervous system to enhance functions such as memory, focus, mood regulation, and neuroprotection
The STEP trials (Semaglutide Treatment Effect in People with obesity) demonstrated that once-weekly semaglutide produced clinically meaningful weight lossup to 22 percent body weight reduction at 2.4 mg doses over 68 weeks
